Terns Pharmaceuticals公司评级遭下调:Mizuho从“跑赢大盘”降至“中性”,目标价微降至53美元

美股速递
Mar 27

Mizuho证券近日调整了对Terns Pharmaceuticals公司的投资评级,由原先的“跑赢大盘”下调至“中性”,同时将其目标股价从54美元小幅调降至53美元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10